Regulators Allow Rise in Impurities in Anti-Smoking Drug

Federal drug regulators announced that they will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer halted distribution of its Chantix branded varenicline.